HELSINKI, Finland

Janne Nikkilä

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: International N&h Denmark Aps. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Janne Nikkilä: Innovator in Probiotic Bacteria

Introduction

Janne Nikkilä is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of probiotics, particularly through his innovative research on bacteria that can interact with blood type antigens. His work aims to enhance health and wellness through the use of beneficial microorganisms.

Latest Patents

Janne Nikkilä holds a patent related to bacteria and their metabolites that are capable of binding to A, B, and/or O blood type antigens. This invention also focuses on bacteria that are acid and/or bile tolerant. The patent outlines their use in probiotic compositions and food products, as well as methods for selecting these beneficial bacteria. Furthermore, it discusses the potential applications of these bacteria and metabolites in the prevention and/or treatment of gastrointestinal disorders. He has 1 patent to his name.

Career Highlights

Janne Nikkilä is currently associated with International N&H Denmark Aps, where he continues to explore the potential of probiotics in improving human health. His research has positioned him as a key figure in the development of innovative probiotic solutions.

Collaborations

Some of his notable coworkers include Heli Putaala and Sofia Forssten, who contribute to the collaborative efforts in advancing probiotic research.

Conclusion

Janne Nikkilä's work in the field of probiotics showcases his commitment to enhancing health through innovative bacterial solutions. His contributions are paving the way for new treatments and dietary options that can benefit many individuals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…